Search scope:
排序: Display mode:
Prognostic analysis of chronic myeloid leukemia in Chinese population in an imatinib era
Haiyan He, Yang Shen, Yongmei Zhu, Saijuan Chen
Frontiers of Medicine 2012, Volume 6, Issue 2, Pages 204-211 doi: 10.1007/s11684-012-0202-x
Keywords: imatinib chronic myeloid leukemia complete cytogenetic response
Yinjun Lou, Yafang Ma, Chenyin Li, Sansan Suo, Hongyan Tong, Wenbin Qian, Wenyuan Mai, Haitao Meng, Wenjuan Yu, Liping Mao, Juyin Wei, Weilei Xu, Jie Jin
Frontiers of Medicine 2017, Volume 11, Issue 2, Pages 229-238 doi: 10.1007/s11684-017-0506-y
Keywords: Philadelphia chromosome acute lymphoblastic leukemia imatinib CALLG2008
Xiaojun Huang, Qian Jiang, Jianda Hu, Jianyong Li, Jie Jin, Fanyi Meng, Zhixiang Shen, Ting Liu, Depei Wu, Jianmin Wang, Jianxiang Wang
Frontiers of Medicine 2019, Volume 13, Issue 3, Pages 344-353 doi: 10.1007/s11684-018-0639-7
Keywords: chronic myeloid leukemia (CML) dasatinib tyrosine kinase inhibitor long-term follow-up
A ruptured recurrent small bowel gastrointestinal stromal tumour causing hemoperitoneum
Eric C.H. Lai,Kam Man Chung,Stephanie H.Y. Lau,Wan Yee Lau
Frontiers of Medicine 2015, Volume 9, Issue 1, Pages 108-111 doi: 10.1007/s11684-014-0344-0
Keywords: gastrointestinal stromal tumour hemoperitoneum small bowel GIST small bowel neoplasm imatinib
Lanping Xu,Huanling Zhu,Jianda Hu,Depei Wu,Hao Jiang,Qian Jiang,Xiaojun Huang
Frontiers of Medicine 2015, Volume 9, Issue 3, Pages 304-311 doi: 10.1007/s11684-015-0400-4
In the tyrosine kinase inhibitor (TKI) era, imatinib is the first-line therapy for patients with chronicappropriate treatment regimens for patients with disease that progressed to accelerated phase following imatinib
Keywords: chronic myeloid leukemia imatinib dasatinib nilotinib allogeneic hematopoietic stem cell transplantation
Title Author Date Type Operation
Prognostic analysis of chronic myeloid leukemia in Chinese population in an imatinib era
Haiyan He, Yang Shen, Yongmei Zhu, Saijuan Chen
Journal Article
Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed
Yinjun Lou, Yafang Ma, Chenyin Li, Sansan Suo, Hongyan Tong, Wenbin Qian, Wenyuan Mai, Haitao Meng, Wenjuan Yu, Liping Mao, Juyin Wei, Weilei Xu, Jie Jin
Journal Article
Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving
Xiaojun Huang, Qian Jiang, Jianda Hu, Jianyong Li, Jie Jin, Fanyi Meng, Zhixiang Shen, Ting Liu, Depei Wu, Jianmin Wang, Jianxiang Wang
Journal Article
A ruptured recurrent small bowel gastrointestinal stromal tumour causing hemoperitoneum
Eric C.H. Lai,Kam Man Chung,Stephanie H.Y. Lau,Wan Yee Lau
Journal Article